A meta-analysis of individual patient data from 12 randomized trials including 15,457 patients. Presented as SABCS 2019.
A pooled analysis on therapy response and prognosis of patients with low HR-positive, HER2-negative early breast cancer has been published in European Journal of Cancer
We are happy to inform you that results of several research projects from GBG and collaborative groups will be presented at the upcoming ASCO Annual Meeting 2021, which will take place from 4 to 8 June.
We are delighted to inform you that the first results of the randomized phase III PenelopeB trial have been published in Journal of Clinical Oncology.
An analysis including breast cancer patients with brain metastases from the BMBC registry has been published in Cancers
Registration for the ESMO Breast Cancer Virtual Meeting, taking place 5-8 May 2021 is now open.
GBG Forschungs GmbHMartin-Behaim-Str. 12 | 63263 Neu-Isenburg | Fax +49 6102 7480-440
+49 6102 7480-0 | nfGBGd